---
title: 重庆兴泰濠制药有限公司 (Sintaho) vs Yongtai Technology
slug_a: sintaho
slug_b: yongtaitech
site: cdmo
review_signal_gate: closed
canonical_path: /compare/sintaho/yongtaitech
---

# 重庆兴泰濠制药有限公司 (Sintaho) vs Yongtai Technology

Side-by-side profile data from each company listing on this directory.

## 重庆兴泰濠制药有限公司 (Sintaho)

- Profile: [/companies/sintaho](/companies/sintaho)

重庆兴泰濠制药有限公司 (Sintaho) — China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (4).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Peptide Manufacturing

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Drug Substance (DS)
- HPAPI

## Yongtai Technology

- Profile: [/companies/yongtaitech](/companies/yongtaitech)

Yongtai Technology — Yongtai Technology is a chemical manufacturing and contract services provider based in Linhai, Zhejiang, operating pharmaceutical, agrochemical, and materials business divisions with capabilities in API synthesis and chemical manufacturing.

Services: 2. Modalities: 0. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (2).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing

### Modalities

- Data not yet provided.

### Development capabilities

- Data not yet provided.

### Manufacturing capabilities

- Data not yet provided.